Previous close | 68.62 |
Open | 68.72 |
Bid | 68.77 x 1000 |
Ask | 68.79 x 900 |
Day's range | 68.33 - 68.84 |
52-week range | 48.35 - 68.84 |
Volume | |
Avg. volume | 6,630,077 |
Market cap | 101.141B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 64.31 |
EPS (TTM) | 1.07 |
Earnings date | 24 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 71.96 |
Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.
Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.